Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Auspex Pharmaceuticals, a clinical stage company developing next-generation medicines, has appointed Michael Grey as its new president and CEO and Gary Gilmore as CFO. Mr Grey has also joined the company's board of directors.
Subscribe to our email newsletter
Prior to Auspex, Mr Grey was president and CEO of SGX Pharmaceuticals, which was recently acquired by Eli Lilly. Prior to joining SGX, Mr Grey was president and CEO of Trega Biosciences, which was acquired by Lion bioscience.
Before joining Auspex, Mr Gilmore was CFO of Althea Technologies, a contract manufacturing organization servicing the pharmaceutical and biotechnology industries. Prior to Althea, Mr Gilmore was CFO for Preventsys, which was acquired by McAfee.
Pratik Shah, chairman of Auspex, said: “We are pleased to have Mike and Gary join the Auspex team. Mike’s extensive experience and track record in building companies involved in drug discovery, development, and commercialization, along with Gary’s many years as a senior corporate finance executive, will be invaluable in leading Auspex in the next phase of its development.”